Radiofrequency Ablation, Cryotherapy, and Microwave Ablation for Renal Tumors

  • J. Louis Hinshaw
  • Meghan G. Lubner


Renal tumor ablation is a technique that has rapidly developed over the last decade. Although some questions remain regarding the long-term efficacy and the most appropriate target patient population, the technique has been shown to have excellent short- and midterm results that are comparable to surgery [1–10]. The purpose of this chapter is to briefly discuss the major factors that determine the role and outcome for radiofrequency (RF), microwave, and cryoablations.


Ablation Zone Local Tumor Progression Complete Ablation Microwave Ablation Probe Placement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Atwell TD, Farrell MA, Leibovich BC, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179(6):2136–40. discussion 2140–1.PubMedCrossRefGoogle Scholar
  2. 2.
    Breen DJ, Rutherford EE, Stedman B, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol. 2007;30(5):936–42.PubMedCrossRefGoogle Scholar
  3. 3.
    Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):64–71.PubMedGoogle Scholar
  4. 4.
    Gill IS, Remer EM, Hasan WA, et al. Renal cryoablation: outcome at 3 years. J Urol. 2005;173(6):1903–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter 3rd TC, Lee Jr FT. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol. 2008;191(4):1159–68.PubMedCrossRefGoogle Scholar
  6. 6.
    Littrup PJ, Ahmed A, Aoun HD, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007;18(3):383–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Malcolm JB, Berry TT, Williams MB, et al. Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. J Endourol. 2009;23(6):907–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol. 2003;180(6):1503–8.PubMedGoogle Scholar
  9. 9.
    Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol. 2006;20(8):569–73.PubMedCrossRefGoogle Scholar
  10. 10.
    Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clarke PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189(2):429–36.PubMedCrossRefGoogle Scholar
  11. 11.
    Gontero P, Joniau S, Zitella A, et al. Ablative therapies in the treatment of small renal tumors: how far from standard of care? Urol Oncol. 2010;28(3):251–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007;188(5):1195–200.PubMedCrossRefGoogle Scholar
  13. 13.
    Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):72–80.PubMedGoogle Scholar
  15. 15.
    Allaf ME, Lang E. Bowel separation before percutaneous renal cryoablation. J Urol. 2008;180(2):721.PubMedCrossRefGoogle Scholar
  16. 16.
    Arellano RS, Garcia RG, Gervais DA, Mueller PR. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol. 2009;193(6):1686–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181(5):1315–7.PubMedGoogle Scholar
  18. 18.
    Ginat DT, Saad W, Davies M, Walman D, Erturk E. Bowel displacement for CT-guided tumor radiofrequency ablation: techniques and anatomic considerations. J Endourol. 2009;23(8):1259–64.PubMedCrossRefGoogle Scholar
  19. 19.
    Lee SJ, Choyke LT, Locklin JK, Wood BJ. Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors. J Vasc Interv Radiol. 2006;17(12):1967–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol. 2009;19(9):2180–90.PubMedCrossRefGoogle Scholar
  21. 21.
    Park BK, Kim SH, Byun JY, Kim YS, Kwon GY, Jang IS. CT-guided instillation of 5% dextrose in water into the anterior pararenal space before renal radiofrequency ablation in a porcine model: positive and negative effects. J Vasc Interv Radiol. 2007;18(12):1561–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008;19(7):1034–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16(11):1551–5.PubMedGoogle Scholar
  24. 24.
    Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38(3):135–43.PubMedCrossRefGoogle Scholar
  25. 25.
    Clark PE, Woodruff RD, Zagoria RJ, Hall MC. Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study. AJR Am J Roentgenol. 2007;188(5):1212–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Laeseke PF, Lee Jr FT, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol. 2009;20(9):1224–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113(10):2671–80.PubMedCrossRefGoogle Scholar
  28. 28.
    Bandi G, Hedican S, Moon T, Lee FT, Nakada SY. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. J Endourol. 2008;22(5):963–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol. 2008;19(9):1311–20.PubMedCrossRefGoogle Scholar
  30. 30.
    Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation–initial observations. Radiology. 2005;237(1):366–70.PubMedCrossRefGoogle Scholar
  31. 31.
    Campbell SC, Krishnaumurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52(1):29–33. discussion 33–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Chosy SG, Nakada SY, Lee Jr FT, Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol. 1998;159(4):1370–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Sung GT, Gill IS, Hsu TH, et al. Effect of intentional cryo-injury to the renal collecting system. J Urol. 2003;170(2 Pt 1):619–22.PubMedCrossRefGoogle Scholar
  34. 34.
    Shock SA, Laeseke PF, Sampson LA, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology. 2005;236(1):125–31.PubMedCrossRefGoogle Scholar
  35. 35.
    Lewin JS, Nour SG, Connell CF, et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology. 2004;232(3):835–45.PubMedCrossRefGoogle Scholar
  36. 36.
    Silverman SG, Tuncali K, Adams DF, Nawfel RD, Zou KH, Judy PF. CT fluoroscopy-guided abdominal interventions: techniques, results, and radiation exposure. Radiology. 1999;212(3):673–81.PubMedGoogle Scholar
  37. 37.
    Shingleton WB, Sewell Jr PE. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol. 2001;165(3):773–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Littrup PJ, Jallad B, Vorugu V, et al. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol. 2009;20(10):1343–51.PubMedCrossRefGoogle Scholar
  39. 39.
    Permpongkosol S, Nicol TL, Khurana H, et al. Thermal maps around two adjacent cryoprobes creating overlapping ablations in porcine liver, lung, and kidney. J Vasc Interv Radiol. 2007;18(2):283–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Laeseke PF, Frey TM, Brace CL, et al. Multiple-electrode radiofrequency ablation of hepatic malignancies: initial clinical experience. AJR Am J Roentgenol. 2007;188(6):1485–94.PubMedCrossRefGoogle Scholar
  41. 41.
    del Cura JL, Zabala R, Iriarte JI, Unda M. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications. Eur Urol. 2010;57(3):459–65.PubMedCrossRefGoogle Scholar
  42. 42.
    Atwell TD, Wass CT, Charboneau JW, Callstrom MR, Farrell MA, Sengupta S. Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol. 2006;17(3):573–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Rhim H, Dodd 3rd GD, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24(1):41–52.PubMedCrossRefGoogle Scholar
  44. 44.
    Boss A, Clasen S, Kuczyk M, et al. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. AJR Am J Roentgenol. 2005;185(6):1627–31.PubMedCrossRefGoogle Scholar
  45. 45.
    Park BK, Kim CK. Mechanical ureteral perforation by a radiofrequency electrode during ablation of a renal tumor. Cardiovasc Intervent Radiol. 2009;32(6):1317–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Rouviere O, Badet L, Murat FJ, et al. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Cardiovasc Intervent Radiol. 2008;31(3):595–603.PubMedCrossRefGoogle Scholar
  47. 47.
    Brown DB, Bhayani SB. Persistent urine leak after cryoablation of a renal tumor in a patient with an ileal conduit. J Vasc Interv Radiol. 2007;18(10):1324–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Glasgow SC, Ramachandran S, Csontos KA, Jia J, Mohanakumar T, Chapman WC. Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury. Surgery. 2005;138(1):64–70.PubMedCrossRefGoogle Scholar
  49. 49.
    Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23(2):109–13. discussion 113–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol. 1995;13(4):254–61.PubMedGoogle Scholar
  51. 51.
    Lokken RP, Gervais DA, Arellano RS, et al. Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol. 2007;189(4):845–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology. 2007;243(1):276–83.PubMedCrossRefGoogle Scholar
  53. 53.
    Gupta A, Allaf ME, Kavoussi LR, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175(2):447–52. discussion 452–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of RadiologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations